Insmed | INSM - Despesas Operacionais





Despesas Operacionais Alterar Data
BioMarin Pharmaceutical USD 6.32B 5.69B 2026-06
Cytokinetics USD 207.8M 7.22M 2026-06
DBV Technologies USD 47.9M 2.2M 2026-03
Gilead Sciences USD 3.95B 19.57B 2026-06
Heron Therapeutics USD 40.55M 1.46M 2025-12
Insmed USD 526.79M 20.55M 2026-06
Novartis USD 9.29B 507M 2026-03
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Sarepta Therapeutics USD 387.96M 15.59M 2026-06
Ultragenyx Pharmaceutical USD 289M 16M 2026-06
Vertex Pharmaceuticals USD 2.07B 217.1M 2026-06